trending Market Intelligence /marketintelligence/en/news-insights/trending/ai6kdIlZGUdtp2UZ0JEiNQ2 content esgSubNav
In This List

OrthoPediatrics appoints director

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


OrthoPediatrics appoints director

OrthoPediatrics Corp. appointed Samuel Riccitelli as an independent director, effective Dec. 15.

Riccitelli's appointment brings the company's board to 11 members.

From 2012 to 2017, Riccitelli served as president, CEO and a director of Signal Genetics Inc., a molecular diagnostic company that was sold to Miragen Therapeutics Inc.